Sector Gamma AS’s Globus Medical GMED Stock Holding History

Sector Gamma AS’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-105,381	Closed	-$5.65M	–	29
2024 Q1	$5.65M	Sell	105,381 -128,993	-55%	-$6.93M	1.59%	21
2023 Q4	$12.5M	Buy	234,374 +12,547	+6%	+$612K	3.03%	16
2023 Q3	$11M	Buy	+221,827	New	+$12.4M	2.81%	14

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Sector Gamma AS's GMED Position: Q2 2024 in Review

Sector Gamma AS sold out of Globus Medical (GMED) in Q2 2024, closing a stake of 105,381 shares — an estimated $5.65M sold.

Sector Gamma AS first reported a position in GMED in Q3 2023 and held it in 3 quarters. The position peaked at $12.5M in Q4 2023. 450 funds tracked by Wall St. Rank hold GMED as of Q2 2024.

Sector Gamma AS reported no remaining Globus Medical position as of Q2 2024 after selling out during the quarter.
Sector Gamma AS sold 105,381 Globus Medical shares in Q2 2024, an estimated $5.65M.
Sector Gamma AS first reported a position in Globus Medical in Q3 2023 and held it in 3 quarters.
Sector Gamma AS's Globus Medical position peaked at $12.5M in Q4 2023.
450 funds tracked by Wall St. Rank held Globus Medical as of Q2 2024.

Based on Sector Gamma AS's 13F filing for Q2 2024, filed 9 Aug 2024.